Table 2.
Patients' characteristics at study enrolment
| Patient characteristics | n (%) |
|---|---|
| Total N | 180 |
| Sex† | |
| Men: n (%) | 51 (28) |
| Women: n (%) | 128 (72) |
| Age: median (IQR) | 35 (30-41) |
| Location† | |
| Frontal: n (%) | 68 (39) |
| Temporal: n (%) | 27 (15) |
| Occipital: n (%) | 9 (5) |
| Vertex: n (%) | 2 (1) |
| Generalized: n (%) | 69 (39) |
| Headache score†: median (IQR) | 8 (6-10) |
| Headache duration (days)†: median (IQR) | 10 (5-21) |
| WHO stage†: | |
| I or II: n (%) | 38 (21) |
| III: n (%) | 73 (41) |
| IV: n (%) | 66 (37) |
| Patient on ART: n (%) | 53 (29) |
| Karnofsky performance score†: median (IQR) | 70 (60-80) |
| CD4 count†: median (IQR) | 108 (20-239) |
| Workup classification†: | |
| Focal/febrile | 3 (2) |
| Non-focal/febrile | 19 (11) |
| Focal/afebrile | 11 (6) |
| Non-focal/afebrile | 144 (81) |
† Number of patients with data missing: gender (1), location (5), headache score (6), headache duration (1), WHO stage (3), Karnofsky performance score (4), CD4 (10), workup classification (3).